期刊文献+

乳腺癌X线特征与Ki-67表达的相关性研究 被引量:10

Correlative study of mammographic features and expression of Ki-67 in breast carcinoma
下载PDF
导出
摘要 目的分析乳腺癌X线特征与Ki-67表达的相关性。方法分析经乳腺X线摄影以及手术病理证实的76例乳腺癌患者,将X线所见按肿块(大小、边缘、形态)和钙化(分布、形态)情况进行描述,并与Ki-67的表达进行对照,分析其相关性。结果乳腺癌Ki-67阳性表达的X线特征为肿块直径>2.0cm、类圆形肿块、杆状钙化。结论乳腺癌Ki-67的表达与肿块大小、肿块形态、钙化形态有显著的相关性,根据X线特征可大概推测Ki-67的表达情况。 Objective To investigate the correlation between the mammographic features of breast carcinoma and the expression of Ki-67. Methods A total of 76 patients with breast carcinoma were enrolled to determine the correlation between the mammographic features and the expression of Ki-67. The mammographic features were divided into mass (size, margin, shape) and microcalcification (distribution, shape). Results The mammographic features of Ki-67 positive expression in breast carcinoma were tumor size〉2.0 cm, round mass and rod-shaped calcification. Conclusion The expression of Ki-67 had a significant correlation with the size of tumor, shape of mass, and shape of calcification in breast carcinoma. It is feasible to predict the expression of Ki-67 in breast carcinoma by mammographic features.
出处 《中国医学影像技术》 CSCD 北大核心 2006年第11期1675-1677,共3页 Chinese Journal of Medical Imaging Technology
关键词 乳腺癌 乳腺X线摄影 核增殖抗原Ki-67 Breast neoplasms Mammography Proliferating antigen Ki-67
  • 相关文献

参考文献8

二级参考文献71

  • 1伍烽,王智彪,朱辉,陈文直,白晋,邹建中,黎克全,张喆,曹友德,高根五.高强度聚焦超声体外适形治疗乳腺癌的临床研究[J].中华肿瘤防治杂志,2001,12(z1):135-138. 被引量:3
  • 2刘进康,曾纪珍,周建华.周围型肺腺、鳞癌CT征象与癌细胞核DNA含量关系的研究[J].中华放射学杂志,1996,30(1):15-19. 被引量:55
  • 3Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation [J]. Iht J Cancer, 1983,31 (1):13-20.
  • 4Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms [J]. J Pathol, 1990, 162(4): 285-294.
  • 5Mullerat J, Deroide F, Winslet MC, et al. Proliferation and p53expression in anal cancer precursor lesions [J]. Anticancer Res,2003, 23 (3C): 2995-2999.
  • 6Liu M, Lawson G, Delos M, et al. Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations [J]. Head Neck,2003,25(4): 280-288.
  • 7Tut VM, Braithwaite AL, Angus B, et al. Gyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53,wafl, pRb and Ki67 [J]. Br J Gancer,2001, 84(2): 270-275.
  • 8Bhatavdekar JM, Patel DD, Shah NG,et al. Prognostic significance of immunohisto-chemically localized biomarkers in stage Ⅱ and stage Ⅲ breast cancer: a multivariate analysis [J] . Ann Surg Oncol,2000, 7 (4): 305-311.
  • 9Vincent-Salomon A, Rousseau A, Jouve M, et al. Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy [J]. Eur J Cancer,2004(40): 1502-1508.
  • 10Nakopoulou L, Stefanaki K, Panayotopoulou E, et al. Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation [J]. Hum Pathol,2002,33(9): 863-870.

共引文献300

同被引文献93

引证文献10

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部